Cue BiopharmaCUE
13F holders, Q2 2026 (June 30)1holders −54
0new positions
54sold out
$0.55avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Cue Biopharma Inc. (CUE) in their 13F filings, down 54 from Q1 2026. 0 opened new positions and 54 sold out. The largest holder was IFP Advisors, Inc ($55).
- Company
- Cue Biopharma Inc.
- CUSIP
- 22978P106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 54 | $5.0M |
All 13F filers, Q1 2026 → Q2 2026: 21,413,261 shares sold, net −21,413,261 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| IFP Advisors, Inc | 0.00% | No change | 100 | $55 |
"% of holder's portfolio" is CUE's weight in each manager's 13F, not the share of Cue Biopharma Inc. the manager owns.